Prosecution Insights
Prosecution Insights
17 pending office actions • 12 clients • 17 examiners • 14 art units • 0 of 17 (0%) have an AI response strategy ready • 28 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 16 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 16 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 11 (65%) |
| §102 only | 2 (12%) |
| §112 only | 1 (6%) |
| No statute on record | 3 (18%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| POTHEN, FEBA | 1 | 81.1% | +12.0% |
| TIMILSINA, SHARAD | 1 | 79.2% | +15.5% |
| IVANOVA, SVETLANA M | 1 | 50.5% | +51.9% |
| KIM, SEONG JONG | 1 | — | — |
| ELHILO, EISA B | 1 | 83.2% | +15.8% |
| BAEK, JONGHWAN NMN | 1 | 66.7% | +0.0% |
| FETTEROLF, BRANDON J | 1 | 49.5% | +14.6% |
| ZINGARELLI, SANDRA | 1 | 8.0% | +45.7% |
| HERNANDEZ, JACKSON J | 1 | 52.8% | +51.5% |
| HIRAKIS, SOPHIA P | 1 | 41.2% | +74.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18345309 | ENHANCED EXTRACTION OF NATURAL PRODUCTS FROM BIOMASS | ELHILO, EISA B | 58d overdue |
| 18633985 | PHOTOIONIZATION DETECTOR | POTHEN, FEBA | 13d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18300640 | RAPID ANTIBIOTIC SUSCEPTIBILITY TESTING | ZINGARELLI, SANDRA | 10d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17999447 | PHARMACEUTICAL COMPOSITION CAPABLE OF INHIBITING REPLICATION OF CORONAVIRUS | HERNANDEZ, JACKSON J | 93d overdue |
| 18551559 | SENSING SYSTEM | TIMILSINA, SHARAD | 77d overdue |
| 18345309 | ENHANCED EXTRACTION OF NATURAL PRODUCTS FROM BIOMASS | ELHILO, EISA B | 58d overdue |
| 17771896 | COMPOUNDS AND METHODS FOR POTENTIATING COLISTIN ACTIVITY | HIRAKIS, SOPHIA P | 44d overdue |
| 18300640 | RAPID ANTIBIOTIC SUSCEPTIBILITY TESTING | ZINGARELLI, SANDRA | 10d overdue |
| 18633985 | PHOTOIONIZATION DETECTOR | POTHEN, FEBA | 13d |
| 18035011 | METHODS OF TREATING CORONAVIRUS DISEASE AND COMPOUNDS FOR SAME | FETTEROLF, BRANDON J | 28d |
| 18548580 | FABI INHIBITORS FOR GRAM-NEGATIVE PATHOGENS | IVANOVA, SVETLANA M | 54d |
| Art Unit | Apps |
|---|---|
| 1627 | 3 |
| 1658 | 2 |
| 2858 | 1 |
| 2857 | 1 |
| 1621 | 1 |
| 1761 | 1 |
| 1618 | 1 |
| 1626 | 1 |
| 1653 | 1 |
| 1623 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18633985 | PHOTOIONIZATION DETECTOR | Alphasense Limited | POTHEN, FEBA | 2858 | §103 | Non-Final OA | 13d | Pending | Apr 12, 2024 |
| 18551559 | SENSING SYSTEM | Alphasense Limited | TIMILSINA, SHARAD | 2857 | §103 | Non-Final OA | 77d overdue | Pending | Sep 20, 2023 |
| 18548580 | FABI INHIBITORS FOR GRAM-NEGATIVE PATHOGENS | The Broad Institute, Inc. | IVANOVA, SVETLANA M | 1627 | §102 | Non-Final OA | 54d | Pending | Sep 01, 2023 |
| 18261373 | ANTIBIOTICS WITH IMPROVED DRUG RESISTANCE PROFILE | The Board Of Trustees Of The University Of Illinois | KIM, SEONG JONG | 1621 | §102 | Non-Final OA | 21d | Pending | Jul 13, 2023 |
| 18345309 | ENHANCED EXTRACTION OF NATURAL PRODUCTS FROM BIOMASS | The Board Of Trustees Of The University Of Illinois | ELHILO, EISA B | 1761 | §112 | Non-Final OA | 58d overdue | Pending | Jun 30, 2023 |
| 18253857 | SYNTHESIS OF [18F]-LABELED THYMIDINE ANALOGUES | UNIVERSITY OF SOUTHERN CALIFORNIA | BAEK, JONGHWAN NMN | 1618 | Other | Non-Final OA | 15d | Pending | May 22, 2023 |
| 18035011 | METHODS OF TREATING CORONAVIRUS DISEASE AND COMPOUNDS FOR SAME | Michal Brylinski | FETTEROLF, BRANDON J | 1626 | §103 | Final Rejection | 28d | Pending | May 02, 2023 |
| 18300640 | RAPID ANTIBIOTIC SUSCEPTIBILITY TESTING | Iowa State University Research Foundation, Inc. | ZINGARELLI, SANDRA | 1653 | §103 | Non-Final OA | 10d overdue | Pending | Apr 14, 2023 |
| 17999447 | PHARMACEUTICAL COMPOSITION CAPABLE OF INHIBITING REPLICATION OF CORONAVIRUS | Mahidol University | HERNANDEZ, JACKSON J | 1627 | §103 | Final Rejection | 93d overdue | Pending | Nov 21, 2022 |
| 17771896 | COMPOUNDS AND METHODS FOR POTENTIATING COLISTIN ACTIVITY | UNIVERSITY OF NOTRE DAME DU LAC | HIRAKIS, SOPHIA P | 1623 | §103 | Final Rejection | 44d overdue | Pending | Apr 26, 2022 |
| 17626888 | SYNERGISTIC COMBINATION OF S-KETOROLAC AND PREGABALIN IN A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF NEUROPATHIC PAIN | Carlos Amezcua Amezcua | JUSTICE, GINA CHIEUN YU | 1617 | §103 | Final Rejection | — | Pending | Jan 13, 2022 |
| 17615402 | PROCASPASE-3 ACTIVATION AND IMMUNOTHERAPY FOR TREATMENT OF CANCER | The Board Of Trustees Of The University Of Illinois | HASTINGS, ALISON AZAR | 1627 | Other | Non-Final OA | 138d overdue | Pending | Nov 30, 2021 |
| 17494110 | COMPOUNDS THAT INDUCE FERROPTIC CELL DEATH | The Board Of Trustees Of The University Of Illinois | MAHLUM, JONATHAN DAVIS | 1625 | §103 | Non-Final OA | 126d overdue | Pending | Oct 05, 2021 |
| 17493546 | LIPID COMPOSITIONS WITH HIGH DHA CONTENT | Arctic Bioscience AS | LEE, JIA-HAI | 1658 | §103 | Non-Final OA | 81d overdue | Pending | Oct 04, 2021 |
| 17377159 | OCULAR COMPOSITIONS AND METHODS | Silk Technologies, Ltd. | REYNOLDS, FRED H | 1658 | Other | Final Rejection | 14d | Pending | Jul 15, 2021 |
| 17291169 | PHARMACEUTICAL COMPOSITION WHICH COMPRISES THE COMBINATION OF A SELECTIVE INHIBITOR OF CYCLOOXYGENASE 2 AND A CARBAMATE DERIVED FROM GUAIFENESIN FOR TREATING PAIN, INFLAMMATION AND MUSCULAR CONTRACTION | Carlos Amezcua Amezcua | BAEK, BONG-SOOK | 1611 | §103 | Final Rejection | 2d overdue | Pending | May 04, 2021 |
| 16094791 | ISOLATION OF PLANT EXTRACTS | Plant Extraction, LLC (A Georgia Limited Liability Company) | BOECKELMAN, JACOB A | 1655 | §103 | Non-Final OA | 53d | Pending | Oct 18, 2018 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial